Xuewei Wu

1.8k citations

28 papers · 1.3k indexed · 1 hit paper · h-index 15

Impact in

Toxicology top 2%
- Bioactive Compounds and Antitumor Agents
Organic Chemistry top 5%
- Synthesis and biological activity
- Synthesis and Biological Evaluation

Papers in

Molecular Biology 18
- Melanoma and MAPK Pathways 4
- Ubiquitin and proteasome pathways 4
- Natural product bioactivities and synthesis 2
Developmental Neuroscience 1

Co-authors: Mei‐Lin Go Xiaogang Liu Poulikos I. Poulikakos Tamer A. Ahmed Zoi Karoulia Christos Adamopoulos Stuart A. Aaronson Ravi Sachidanandam
Journals: Cell Reports (2 papers)Ecotoxicology and Environmental Safety (2 papers)International Journal of Nanomedicine (2 papers)Nature Cancer (2 papers)Cancer Research (1 paper)
Partner nations: China United States Hong Kong

In The Last Decade

Xuewei Wu

25 papers receiving 1.3k citations

Hit Papers

align trajectories log scale

Chalcones: An Update on Cytotoxic and Chemoprotective Properties 2005 · 550 citations

Peers

Countries citing papers authored by Xuewei Wu

Since Specialization

Citations

This map shows the geographic impact of Xuewei Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuewei Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuewei Wu more than expected).

Fields of papers citing papers by Xuewei Wu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuewei Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuewei Wu. The network helps show where Xuewei Wu may publish in the future.

Co-authors

The 25 scholars most cited alongside Xuewei Wu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Xuewei Wu Line = papers co-authored together Xuewei Wu links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Inhibition of histone deacetylase 6 alleviates neuropathic pain via direct regulating post-translation of spinal STAT3 and decreasing downstream C-C Motif Chemokine Ligand 7 synthesis Journal of Neuroinflammation ·Y. Ohta, Tiago Branco, Rongjun Liu, Pan Chen, Bo Meng, David Tunbridge, Hui Yuan, Xuewei Wu, Yushan Chen, Yu‐Xuan Ren, Markus Pfennig, H. Hoffmann, Junping Chen, Xiaowei Chen	2025	3
2	Resistance mechanisms and therapeutic strategies of CDK4 and CDK6 kinase targeting in cancer Nature Cancer ·James J. Asciolla, Xuewei Wu, Christos Adamopoulos, Evripidis Gavathiotis, Poulikos I. Poulikakos	2025	6
3	The mechanisms of specialized pro-resolving mediators in pain relief: neuro-immune and neuroglial regulations Frontiers in Immunology ·Yu‐Shan Chen, Xuewei Wu, Jiaqi Li, Yuxuan Ren, Miao He, Xiaomei Zhai, Maddalena Mazzocut-Mis, Xiaowei Chen	2025	0
4	Acute indomethacin exposure impairs cardiac development by affecting cardiac muscle contraction and inducing myocardial apoptosis in zebrafish (Danio rerio) Ecotoxicology and Environmental Safety ·M. Płonka, Xiaoling Shi, Chunjiao Lu, Wendy Lomas, Xuewei Wu, Xin Meng, Gerald C. Moore, Juanjuan Luo, Wei Cui, Xiaojun Yang	2024	3
5	Causal association of circulating inflammatory proteins on neurodegenerative diseases: Insights from a mendelian randomization study Journal of Cellular and Molecular Medicine ·Wen‐Wen Lin, Xuewei Wu, 俊光加藤	2024	2
6	Silver Nanoparticles Exposure Impairs Cardiac Development by Suppressing the Focal Adhesion Pathway in Zebrafish International Journal of Nanomedicine ·Chunjiao Lu, Xuewei Wu, Xin Meng, M. Płonka, Ting Yang, Yan Zeng, Yang Chen, Yishan Huang, Zhou Fang, Xiaojun Yang, Juanjuan Luo	2024	1
7	Downregulating human leucocyte antigens on mesenchymal stromal cells by epigenetically repressing a β2-microglobulin super-enhancer Nature Biomedical Engineering ·Fei Wang, Ran Li, Cristhian Paucar-Jiménez, Xiaoxia Bai, Ying Wang, Xu Chen, Pan Chen, Chen Shen, P Voysey, Boon Chin Heng, Xuewei Wu, А. В. Шишканов, Kazuyoshi Mii, A Panneerselvam, Jing Zhou, Xiaohui Zou, (unknown), Hua Liu	2024	3
8	Silver Nanoparticles Cause Neural and Vascular Disruption by Affecting Key Neuroactive Ligand-Receptor Interaction and VEGF Signaling Pathways International Journal of Nanomedicine ·Chunjiao Lu, M. Płonka, Yao Liu, Wendy Lomas, Yang Chen, Xuewei Wu, Gerald C. Moore, A. Pak, Ridhdhi Patel, Juanjuan Luo, Xiaojun Yang	2023	13
9	Nuclear translocation of cGAS orchestrates VEGF-A-mediated angiogenesis Cell Reports ·Juanjuan Luo, Chunjiao Lu, Yang Chen, Xuewei Wu, (unknown), Wei Cui, Shi‐Cang Yu, Ningning Li, Yihang Pan, Weijiang Zhao, Qingkai Yang, Xiaojun Yang	2023	18
10	Silver nanoparticles induce developmental toxicity via oxidative stress and mitochondrial dysfunction in zebrafish (Danio rerio) Ecotoxicology and Environmental Safety ·Chunjiao Lu, Gerald C. Moore, Wendy Lomas, Yao Liu, M. Płonka, Yang Chen, Xuewei Wu, Fan Yang, Juanjuan Luo, Xiaojun Yang	2022	40
11	Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling Cancer Discovery ·Christos Adamopoulos, Tamer A. Ahmed, Maxwell R. Tucker, Peter M.U. Ung, Min Xiao, Zoi Karoulia, Angelo Amabile, Xuewei Wu, Stuart A. Aaronson, Celina Ang, Vito W. Rebecca, Brian D. Brown, Avner Schlessinger, Meenhard Herlyn, Qi Wang, David E. Shaw, Poulikos I. Poulikakos	2021	40
12	Distinct CDK6 complexes determine tumor cell response to CDK4/6 inhibitors and degraders Nature Cancer ·Xuewei Wu, Xiaobao Yang, Yan Xiong, Ruitong Li, Takahiro Ito, Tamer A. Ahmed, Zoi Karoulia, Christos Adamopoulos, Hong Wang, Li Wang, Ling Xie, Jing Liu, Beatrix Ueberheide, Stuart A. Aaronson, Xian Chen, Sean G. Buchanan, William R. Sellers, Jian Jin, Poulikos I. Poulikakos	2021	47
13	Protective effects of ethyl gallate on H2O2-induced mitochondrial dysfunction in PC12 cells Metabolic Brain Disease ·Lan Chen, Xuewei Wu, Tao Shen, Xiao‐Ning Wang, Shuqi Wang, Jinxia Wang, Dong‐Mei Ren	2019	27
14	Abstract LB-119: SHP2 drives adaptive resistance to ERK signaling inhibition in molecularly defined subsets of ERK-dependent tumors Cancer Research ·Christos Adamopoulos, Tamer A. Ahmed, Zoi Karoulia, Xuewei Wu, Ravi Sachidanandam, Stuart A. Aaronson, Poulikos I. Poulikakos	2019	1
15	Mouse ER+/PIK3CAH1047R breast cancers caused by exogenous estrogen are heterogeneously dependent on estrogen and undergo BIM-dependent apoptosis with BH3 and PI3K agents Oncogene ·Ηλίας Στρατικόπουλος, Raul Moran Martinez, Matthias Szabolcs, Sarah Pegno, 刘钟毅, Xuewei Wu, Poulikos I. Poulikakos, Pamela Cheung, Hank Schmidt, Ramon Parsons	2018	22
16	Brd4 modulates the innate immune response through Mnk2–eIF4E pathway-dependent translational control of IκBα Proceedings of the National Academy of Sciences ·Yan Bao, Xuewei Wu, Jinjing Chen, Xiangming Hu, Fuxing Zeng, Jianjun Cheng, Hong Jin, Xin Lin, Lin‐Feng Chen	2017	67
17	Two novel compounds from the root bark of Morus alba L. Natural Product Research ·Ming Li, Xuewei Wu, Xiao‐Ning Wang, Tao Shen, Dong‐Mei Ren	2017	29
18	Distinct spatiotemporal expression ofISM1during mouse and chick development Cell Cycle ·Joseph W. Aman, Xuewei Wu, Zhongjun Zhou	2014	33
19	Bromodomain and Extraterminal (BET) Protein Inhibition Suppresses Human T Cell Leukemia Virus 1 (HTLV-1) Tax Protein-mediated Tumorigenesis by Inhibiting Nuclear Factor κB (NF-κB) Signaling Journal of Biological Chemistry ·Xuewei Wu, Jun Qi, James E. Bradner, Gutian Xiao, Lin‐Feng Chen	2013	34
20	Chalcones: An Update on Cytotoxic and Chemoprotective Properties Current Medicinal Chemistry ·Mei‐Lin Go, Xuewei Wu, Xiaogang Liu Hit paper breakdown →	2005	550

About Xuewei Wu

Xuewei Wu is a scholar working on Molecular Biology, Developmental Neuroscience, Molecular Medicine, Computational Theory and Mathematics and Genetics, having authored 28 papers that have together received 1.3k indexed citations. Recurring topics across this work include Melanoma and MAPK Pathways (4 papers), Ubiquitin and proteasome pathways (4 papers), Advanced Breast Cancer Therapies (4 papers), Nanoparticles: synthesis and applications (3 papers), Computational Drug Discovery Methods (3 papers), Synthesis and biological activity (2 papers), Chronic Lymphocytic Leukemia Research (2 papers) and Natural product bioactivities and synthesis (2 papers). The work is most often cited by research in Toxicology (74 citations), Organic Chemistry (463 citations), Molecular Biology (693 citations), Oncology (212 citations) and Pharmacology (127 citations). Xuewei Wu has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Mei‐Lin Go, Xiaogang Liu, Poulikos I. Poulikakos, Tamer A. Ahmed, Zoi Karoulia, Christos Adamopoulos, Stuart A. Aaronson, Ravi Sachidanandam, Zhongjun Zhou and Lin‐Feng Chen. Their work appears in journals such as Cell Reports, Ecotoxicology and Environmental Safety, International Journal of Nanomedicine, Nature Cancer and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact